ArticlePlant communications2026
Synthetic communities and metabolite-driven enrichment of keystone rhizosphere microbial taxa suppress bacterial wilt disease in peanut.
Article in Plant communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Host genetic variation is associated with root-associated microbiome assembly and resistance to Fusarium oxysporum in tobacco.Plant physiology · 2026Article
- Engineering rhizobacterial communities for soil and plant health.Microbiology (Reading, England) · 2026Review
- Article
- Synthetic microbial communities for plant growth promotion and soil-borne disease suppression: design principles, mechanisms, and translational challenges.Frontiers in microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Resistant cultivars play important roles in controlling pathogen invasion in peanut. However, it remains unclear whether and how the metabolites secreted by resistant cultivars and the keystone microbes enriched in their rhizosphere can compensate for the lack of pathogen resistance in susceptible cultivars. In this study, we investigated the roles of metabolites and rhizosphere microbes from resistant peanut cultivars in controlling bacterial wilt disease caused by Ralstonia solanacearum using pot experiments coupled with multi-omics analyses and cultivation assays. R. solanacearum inoculation significantly decreased microbial diversity and network complexity in susceptible cultivars, whereas it increased network complexity in resistant cultivars. Under R. solanacearum inoculation, the rhizosphere of resistant cultivars exhibited significant enrichment of several metabolic pathways related to plant health, including streptomycin, phenylpropanoid, and isoflavonoid biosynthesis. In addition, inoculation induced the recruitment of three putative keystone microbial taxa (Bacillus, Pseudomonas, and Talaromyces), which were significantly correlated with four key metabolites (citrulline, L-phenylalanine, kaempferol, and isopimpinellin) that promoted the growth of these taxa in vitro. Combined application of a synthetic community (SynCom4) and metabolites was more effective than SynCom4 alone in suppressing bacterial wilt in peanut and enriched additional beneficial microbes, including Bacillus, Pseudomonas, Talaromyces, Glutamicibacter, Penicillium, Microbacterium, Curtobacterium, and Stenotrophomonas. These microbes further enhanced peanut resistance against R. solanacearum by activating the host immune system and inducing the synthesis of lignin and antimicrobial compounds (quercetin, dihydroquercetin, and cyanidin). In summary, our work provides a mechanistic understanding of how resistant cultivars modulate their rhizosphere microbiota through metabolite-mediated regulation to combat R. solanacearum invasion in peanut and highlights the importance of interactions between keystone microbes and key metabolites in disease suppression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.